Page last updated: 2024-11-02

4-phenylbutyric acid and Cancer of Kidney

4-phenylbutyric acid has been researched along with Cancer of Kidney in 2 studies

4-phenylbutyric acid: RN refers to the parent cpd
4-phenylbutyric acid : A monocarboxylic acid the structure of which is that of butyric acid substituted with a phenyl group at C-4. It is a histone deacetylase inhibitor that displays anticancer activity. It inhibits cell proliferation, invasion and migration and induces apoptosis in glioma cells. It also inhibits protein isoprenylation, depletes plasma glutamine, increases production of foetal haemoglobin through transcriptional activation of the gamma-globin gene and affects hPPARgamma activation.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Deng, Q1
Liang, L1
Liu, Q1
Duan, W1
Jiang, Y1
Zhang, L1
He, C1
Zhao, X1
Jiang, H1
Zhong, Z1
Xu, R1

Other Studies

2 other studies available for 4-phenylbutyric acid and Cancer of Kidney

ArticleYear
Autophagy is a major mechanism for the dual effects of curcumin on renal cell carcinoma cells.
    European journal of pharmacology, 2018, May-05, Volume: 826

    Topics: Acetylcysteine; AMP-Activated Protein Kinases; Antineoplastic Agents; Autophagy; Carcinoma, Renal Ce

2018
Demethylation of miR-10b plays a suppressive role in ccRCC cells.
    International journal of clinical and experimental pathology, 2015, Volume: 8, Issue:9

    Topics: Azacitidine; Carcinoma, Renal Cell; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation;

2015